Simply Wall St.16d agoneutral
TransMedics Unveils CHOPS As Trials Progress And Valuation Screens UndervaluedTransMedics Group unveiled its Controlled Hypothermic Organ Preservation System, or CHOPS, a new active cooling device for donor organ storage. The company outlined plans for CHOPS to serve as the control arm in the ENHANCE Heart Part B and DENOVO Lung clinical trials. These updates add a new organ preservation platform alongside TransMedics Group's existing transplant technology programs. TransMedics Group (NasdaqGM:TMDX) is drawing attention with CHOPS at a time when its share price...